Skip to main content

Posts

Showing posts with the label Allergan plc

Peptide Based Cancer Therapeutics Market Expectations Acme Prominent Development in Developed Regions, details Fact.MR study

The purpose of this comprehensive forecast report presented by Fact.MR is to elaborate the various market projections impacting the global peptide based cancer therapeutics market during the period through 2018-2028. This assessment delivers high-end statistics concerning market size, growth in trends and revenue share (US& Mn) linked to different geographies and segmentation types. Readers can acquire precise insights about market growth trends along with upcoming opportunities that are expected to reshape the overall structure of the peptide based cancer therapeutics market during the forecast period. The scope of FactMR’s report is to analyze the global peptide based cancer therapeutics market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Drug manufacturers, research institutes, and raw material suppliers in the global peptide based cancer therapeutics market can benefit from the analysis offered in this report. Get a Free Sample R...

Imminence of New Gonorrhea Therapeutic Drugs is Evident as the Bacteria Grow ‘Super Resistant’ to Antibiotics: FactMR

According to a new study of FactMR, the gonorrhea therapeutics market will reach ~US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over 2018. The gonorrhea therapeutics industry will remain influenced by increased attention on new developments in novel therapeutic compounds or antimicrobials for improving the success potential of future treatment. There has been a significant rise in the prevalence of gonorrhea that is resistant to components of dual antibiotic therapy – ceftriaxone and azithromycin, which is the only recommended treatment for gonorrhea. In addition, resistance to several other antibiotics apart from dual antibiotic therapy resulted in ‘super gonorrhea’, which has become a buzzword in the gonorrhea therapeutics market . With a slew of promising new antibiotics on the horizon, alongside surveillance, education and preventative measures to stymie prevalence of super-resistant gonorrhea, prospects seem bullish for the gonorrhea therapeutics market. Request S...

Peptide Based Gastrointestinal Disorders Therapeutics Market Estimated to Record Highest CAGR by 2017 to 2022

In order to dissert the market scenario prevailing across the peptide based gastrointestinal disorders therapeutics market sector, Fact.MR has evenly presented a comprehensive analysis report on peptide based gastrointestinal disorders therapeutics market to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the peptide based gastrointestinal disorders therapeutics market in the coming years. In addition, factors such as market size, Y-o-Y growth and revenue share are investigated so as to make this research highly authentic and reliable. Get Free Sample Report from Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=190 Medical research institutes as well as leading companies in the pharmaceutical industry are ramping up their efforts toward development of profound therapeutic drugs fo...